Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HengLi in Post-stroke Upper Limb Spasticity
NCT02280083Phase 3Completed
- Sponsor
- Lanzhou Institute of Biological Products Co., Ltd.
- Start
- Jul 2014
- Primary completion
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of lanbotulinumtoxin-A in Upper limb spasticity, sponsored by Lanzhou Institute of Biological Products Co., Ltd.. Started Jul 2014; status: completed.
02
Drugs
lanbotulinumtoxin-A
03
Conditions
Upper limb spasticity
Beyond the preview
Go deeper on NCT02280083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02280083.